Description

Dexlansoprazole Delayed Release Capsules 60 mg

Dexpentral-60 Capsules contain Dexlansoprazole 60 mg, a next-generation proton pump inhibitor (PPI) designed for the effective treatment of GERD (Gastroesophageal Reflux Disease), erosive esophagitis, and other acid-related gastrointestinal conditions.

Dexlansoprazole selectively inhibits the H+/K+ ATPase enzyme (proton pump) in the stomach lining. This action prevents the secretion of gastric acid, helping to:

• Relieve heartburn and acid reflux symptoms.

• Promote healing of the esophagus in erosive conditions.

• Prevent recurrence of GERD and ulcer symptoms.

Key Benefits of Dexpentral-60 Capsules –

Provides 24-hour control of gastric acid with once-daily dosing.

Dual delayed-release technology ensures fast and sustained relief.

Effective in healing erosive esophagitis and preventing recurrence.

Reduces nocturnal acid breakthrough, improving sleep quality.

Convenient dosing that improves treatment compliance.